Immunotherapy for GU Ca: A primer for urologists – ModernMedicine
|
Immunotherapy for GU Ca: A primer for urologists
ModernMedicine Immunotherapy for genitourinary malignancies is not new, as high-dose interleukin-2 (IL-2 [Proleukin]) for metastatic renal cell carcinoma (mRCC) and intravesical bacillus Calmette-Guérin for high-grade bladder cancer have been used since the 1990s. |
